Research reading
Medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale demand and the China (CHN) to Myanmar (MMR) lane
Myanmar (MMR) reported $1.9M of medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale imports in 2022. China (CHN) accounted for 0% of the observed market and reported $110.7 in exports on this lane.
The latest annual values eased slightly, while the longer available history shows +19.6% buyer growth and -1.6% exporter growth. The page separates reported values from projections and indicators.
